HIF-1α: a Valid Therapeutic Target for Tumor Therapy
Author:
Affiliation:
1. Research Institute of Pharmaceutical Sciences and College of Pharmacy, Seoul National University, Seoul 151-742, Korea.
Publisher
Korean Cancer Association
Subject
Cancer Research,Oncology
Link
http://www.e-crt.org/upload/pdf/crt-36-343.pdf
Reference114 articles.
1. Angiogenesis in cancer and other diseases
2. HIF-1: master and commander of the hypoxic world
3. Targeting HIF-1 for cancer therapy
4. Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma
5. Effect of Protein Kinase and Phosphatase Inhibitors on Expression of Hypoxia Inducible Factor 1
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Novel benzochromenes: design, synthesis, cytotoxicity, molecular docking and mechanistic investigations;Future Medicinal Chemistry;2024-01
2. A comprehensive review on therapeutic potentials of photobiomodulation for neurodegenerative disorders;Life Sciences;2024-01
3. Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studies;EJNMMI Research;2023-11-25
4. Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease;Cell Reports Medicine;2023-11
5. Exploring mRNA translation strategies for hypoxia adaptation across distantly related metazoans;Epigenomics;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3